Sclerotherapy of varicose veins with polidocanol based on the guidelines of the german society of phlebology: Original articles

Dermatologic Surgery

Volumn 36, Issue SUPPL. 2, 2010, Pages 968-975

  Rabe, Eberhard ^a   Pannier, Felizitas ^b  

^a UNIVERSITY OF BONN   (Germany)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

POLIDOCANOL;

ANAMNESIS; ANAPHYLAXIS; ARTICLE; CLINICAL EXAMINATION; CONTACT URTICARIA; DOPPLER FLOWMETRY; DRUG EFFICACY; DRUG INDUCED HEADACHE; ERYTHEMA; EVIDENCE BASED MEDICINE; FOAM SCLEROTHERAPY; GERMANY; HUMAN; INTERMETHOD COMPARISON; LIQUID SCLEROTHERAPY; MEDICAL LITERATURE; MEDICAL SOCIETY; MIGRAINE; PATIENT SAFETY; PHLEBOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RISK BENEFIT ANALYSIS; SCLEROTHERAPY; SKIN ALLERGY; SPIDER VEIN; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT PLANNING; VARICOSIS;

GERMANY; HUMANS; POLYETHYLENE GLYCOLS; SCLEROSING SOLUTIONS; SCLEROTHERAPY; VARICOSE VEINS;

EID: 77952916152     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01495.x     Document Type: Article

References (63)

1. Rabe E, Pannier-Fischer F, Gerlach H, et al. Guidelines for sclerotherapy of varicose veins. Dermatol Surg 2004 30 : 687 693.
2. Drake LA, Dinehart SM, Goltz RW, et al. Guidelines of care for sclerotherapy treatment of varicose and telangiectatic leg veins. J Am Acad Dermatol 1996 34 : 523 528.
3. Rabe E, Pannier F, Gerlach H, et al. Leitlinie sklerosierungsbehandlung der varikose. Phlebologie 2008 37 : 27 34.
4. Einarsson E, Eklöf B, Neglén P. Sclerotherapy or surgery as treatment for varicose veins: a prospective randomized study. Phlebology 1993 8 : 22 6.
5. Malouf GM. Ambulatory venous surgery versus sclerotherapy. Hawaii Med J 2000 59 : 248 249.
6. Bullens-Goessens YI, Mentink LF, Nelemans PJ, et al. Ultrasound-guided sclerotherapy of the insufficient short saphenous vein. Phlebol Germany 2004 33 : 89 91.
7. Schultz-Ehrenburg U, Tourbier H. Doppler-kontrollierte verödungsbehandlung der vena saphena magna. Phlebol Proktol 1984 13 : 117 122.
8. Vin F. Principes de la sclérothéraphie des troncs saphènes internes. Phlebologie 1997 50 : 229 234.
9. Wright D, Gobin JP. Varisolve European Phase III Investigators Group, et al. Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology 2006 21 : 180 190.
10. Cavezzi A, Frullini A, Ricci S, Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 2002 17 : 13 8.
11. Hamel-Desnos C, Desnos P, Wollmann JC, et al. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the long saphenous vein: initial results. Dermatol Surg 2003 29 : 1170 1175.
12. Hamel-Desnos C, Ouvry P, Benigni JP, et al. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2-year follow-up. Eur J Vasc Endovasc Surg 2007 34 : 723 729.
13. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Endovasc Vasc Surg 2008 35 : 238 245.
14. Guex JJ, Allaert F-A, Gillet J-L. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005 31 : 123 128.
15. Munavalli GS, Weiss RA. Complications of sclerotherapy. Semin Cutan Med Surg 2007 26 : 22 8.
16. Weiss RA, Weiss MA. Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonic saline vs. polidocanol. J Dermatol Surg Oncol 1990 16 : 800 804.
17. Gillet JL, Guedes JM, Guex JJ, et al. Side effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 2009 24 : 131 138.
18. Feied CF, Jackson JJ, Bren TS, et al. Allergic reactions to polidocanol for vein sclerosis. J Dermatol Surg Oncol 1994 20 : 466 468.
19. Pradalier A, Vincent D, Hentschel V, et al. Allergie aux sclérosants des varices. Rev Fr Allergol 1995 35 : 440 443.
20. Passariello F. Sclerosing foam and patent foramen ovale. The final report. In World Congress of the International Union of Phlebology; 2007 Jun 18-20; Kyoto, Japan. Int Angiol 2007;26: 87
21. Wagdi P. Migräne und offenes foramen ovale: nur ein vorübergehender hoffnungsschimmer? Kardiovasc Med 2006 9 : 32 6.
22. Morrison N, Cavezzi A, Bergan J, Partsch H. Regarding "stroke after varicose vein foam injection sclerotherapy". J Vasc Surg 2006 44 : 224 225.
23. Forlee MV, Grouden M, Moore DJ, et al. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006 43 : 162 164.
24. Breu FX, Marshall M. Sklerotherapie mit Polidocanol in einer angiologisch-phlebologischen Spezialpraxis. Prospektive und retrospektive Erhebung über Ergebnisse und Komplikationen. Phlebologie 2003 32 : 76 80.
25. Myers KA, Jolley D. Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose vein. Eur J Vasc Endovasc Surg 2008 36 : 602 605.
26. Hamel-Desnos C, Ouvry P, Desnos P, et al. Sclérothérapie et thrombophilie: Démarche pour un consensus dans la sclé rothérapie chez les thrombophiles. Phlébologie 2003 56 : 165 169.
27. Breu FX, Guggenbichler S, Wollmann JC. 2nd European Consensus Meeting on Foam Sclerotherapy, 28-30 April 2006, Tegernsee, Germany. Vasa 2008 37 (Suppl 71) : 1 32.
28. Hanisch F, Müller T, Krivocuca M, Winterholler M. Stroke following variceal sclerotherapy. Eur J Med Res 2004 9 : 282 284.
29. Busch RG, Derrick M, Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008 23 : 189 192.
30. Yamaki T, Nozaki M, Sakurai H, et al. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins. Eur J Endovasc Surg 2008 37 : 343 348.
31. Goldman MP, Sadick NS, Weiss RA. Cutaneous necrosis, telangiectatic matting and hyperpigmentation following sclerotherapy. Dermatol Surg 1995 21 : 19 29.
32. Bergan JJ, Weiss RA, Goldman MP. Extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol Surg 2000 26 : 535 542.
33. Geukens J, Rabe E, Bieber T. Embolia cutis medicamentosa of the foot after sclerotherapy. Eur J Dermatol 1999 9 : 132 133.
34. Oesch A, Stirnemann P, Mahler F. The acute ischemic syndrome of the foot after sclerotherapy of varicose veins. Schweiz Med Wochenschr 1984 114 : 1155 1158.
35. Weiss RA, Sadick NS, Goldman MP, Weiss MA. Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg 1999 25 : 105 108.
36. Van der Plas JPL, Lambers JC, van Wersch JW, Koehler PJ. Reversible ischaemic neurological deficit after sclerotherapy of varicose veins. Lancet 1994 343 : 428.
37. Zipper SG. Nervus peronäus-schaden nach varizensklerosierung mit Aethoxysklerol. Versicherungsmedizin 2000 4 : 185 187.
38. Kreussler: Fachinformationen Aethoxysklerol 0,25%/0,5%/1%/2% Stand 06/2005, Aethoxysklerol 3%/4%, Stand 09/2005, Chemische Fabrik Kreussler & Co GmbH (product information sheet).
39. Wollmann JC. The history of sclerosing foams. Dermatol Surg 2004 30 : 694 703.
40. Sadoun S, Benigni JP, Sica M. Étude prospective de l'efficacité de la mousse de sclérosant dans le traitement des varices tronculaires des membres inférieurs. Phlébologie 2002 55 : 259 262.
41. Monfreux A. Traitement sclérosant des troncs saphèniens et leurs collatèrales de gros calibre par la méthode mus. Phlébologie 1997 50 : 351 353.
42. Alos J, Carreno P, Lopez JA, et al. Efficacy and safety of sclerotherapy using Polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 2006 31 : 101 107.
43. Yamaki T, Nozaki M, Sakurai H, et al. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg 2008 47 : 578 584.
44. Ouvry P, Allaert FA, Desnos P, Hamel-Desnos C. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicenter randomised controlled trial with a 2-year follow-up. Eur J Vasc Surg 2008 36 : 366 370.
45. Ceulen RPM, Bullens-Goessens YIJM, Pi-Van De Venne SJA. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with 1-year follow-up. Dermatol Surg 2007 33 : 276 281.
46. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 2004 30 : 718 722.
47. Brodersen JP. Catheter-assisted vein sclerotherapy: a new approach for sclerotherapy of the greater saphenous vein with a double-lumen balloon catheter. Dermatol Surg 2007 33 : 469 475.
48. Wildenhues B. Catheter-assisted foam sclerotherapy: a new minimally invasive method fort he treatment of trunk varicosis of the long and short saphenous veins. Phlebologie 2005 34 : 165 170.
49. Hahn M, Schulz T, Jünger M. Sonographically guided, transcatheter foam sclerotherapy of the great saphenous vein. Medical and economic aspects. Phlebologie 2007 36 : 309 312.
50. Bidewai A, Beresford T, Dialynas M, et al. Balloon control of the saphenofemoral junction during foam sclerotherapy: proposed innovation. J Vasc Surg 2007 46 : 145 147.
51. Kölbel T, Hinchliffe RJ, Lindbal B. Catheter-directed foam sclerotherapy of axial saphenous reflux. Early results. Phlebology 2007 22 : 219 222.
52. De Roos KP, Niemann FH, Neumann HA. Ambulatory phlebectomy versus compression sclerotherapy: results of a randomized controlled trial. Dermatol Surg 2003 29 : 221 226.
53. Myers KA, Jolley D, Clough A, et al. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg 2007 33 : 116 121.
54. Stücker M, Reich S, Hermes N, et al. Safety and efficiency of perilesional sclerotherapy in leg ulcer patients with postthrombotic syndrome and/or oral anticoagulation with Phenprocoumon. JDDG 2006 4 : 734 738.
55. De Waard MM, Der Kinderen DJ. Duplex ultrasonography-guided foam sclerotherapy of incompetent perforator veins in a patient with bilateral venous leg ulcers. Dermatol Surg 2005 31 : 580 583.
56. Hertzman PA, Owens R. Rapid healing of chronic venous ulcers following ultrasound-guided foam sclerotherapy. Phlebology 2007 22 : 34 9.
57. Kahle B, Leng K. Efficacy of sclerotherapy in varicose veins - a prospective, blinded placebo controlled study. Dermatol Surg 2004 30 : 723 728.
58. Kern P, Ramelet AA, Wütschert R, et al. Single-blind, randomized study comparing chromated glycerin, polidocanol solution and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg 2004 30 : 367 372.
59. McCoy S, Evans A, Spurrier N. Sclerotherapy for leg telangiectasia - a blinded comparative trial of polidocanol and hypertonic saline. Dermatol Surg 1999 25 : 381 386.
60. Norris MJ, Carlin MC, Ratz JL. Treatment of essential telangiectasia: effects of increasing concentrations of polidocanol. J Am Acad Dermatol 1989 20 : 643 649.
61. Kern P, Ramelet AA, Wütschert R, Hayoz D. Compression after sclerotherapy for telangiectasias and reticular leg veins. A randomized controlled study. J Vasc Surg 2007 45 : 1212 1216.
62. Goldman PM, Beaudoing D, Marley W, et al. Compression in the treatment of leg teleangiectasia: a preliminary report. J Dermatol Surg Oncol 1990 16 : 322 325.
63. Stanley PRW, Bickerton DR, Campbell WB. Injection sclerotherapy for varicose veins - a comparison of materials for applying local compression. Phlebology 1991 6 : 37 9.